Bicalutamide
Product Images NDC 60505-2642

4 FDA label images from Apotex Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 60505-2642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bicalutamide Chemical Structure (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 01)

Bicalutamide Chemical Structure (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 01)
Chemical structure of Bicalutamide showing its molecular components and the molecular formula C18H14N2O4FS. The structure includes various functional groups and fluorophenyl, trifluoromethyl, and sulfonyl moieties, consistent with the active ingredient Bicalutamide.*
FDA Label Image

Bicalutamide Figure 1 (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 02)

Bicalutamide Figure 1 (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 02)
A line graph showing the proportion of patients not progressing over a time span of days to progression, comparing Bicalutamide plus LHRH-A and Flutamide plus LHRH-A. The y-axis represents the proportion not progressing, and the x-axis represents days from 0 to 1825.*
FDA Label Image

Bicalutamide Figure 2 (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 03)

Bicalutamide Figure 2 (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 03)
A survival curve graph showing the proportion surviving over days to death for two treatment groups: Bicalutamide plus LHRH-A versus Flutamide plus LHRH-A. The y-axis represents survival proportion, and the x-axis represents days to death, extending to 1825 days.*
FDA Label Image

Bicalutamide 50 mg Label (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 04)

Bicalutamide 50 mg Label (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 04)
Label for Bicalutamide Tablets USP 50 mg, supplied in a package of 30 tablets by Apotex Corp. The label includes dosage strength, storage instructions, a warning to keep out of reach of children, and barcode information. Manufactured by Intas Pharmaceuticals Limited, India, for Apotex Corp., Weston, Florida.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.